Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2003
07/10/2003WO2003056326A1 System for monitoring salinity in a water well
07/10/2003WO2003056325A1 Method and device for measuring oxygen content in a closed target space
07/10/2003WO2003056322A1 Fet sensor with a specially configured gate electrode for the highly sensitive detection of analytes
07/10/2003WO2003056321A1 Apparatus for stimulating an animal cell and recording its physiological signal and production and use methods thereof
07/10/2003WO2003056318A2 Method for the determination of nitrogen oxides in an exhaust gas and device for exhaust gas treatment
07/10/2003WO2003056313A1 Sensor system and method
07/10/2003WO2003056310A1 Potassium fluoroionophore
07/10/2003WO2003056301A2 A novel screening method for molecular antagonist using flow-cytometry
07/10/2003WO2003056299A2 Labeling reagent and methods of use
07/10/2003WO2003056298A2 Sensitive coded detection systems
07/10/2003WO2003056296A2 Improved methods for determining binding affinities
07/10/2003WO2003056293A2 Small molecule microarrays
07/10/2003WO2003056292A2 Detection of odours using insects
07/10/2003WO2003056163A1 Test strip and method for determining hdl cholesterol concentration from whole blood of plasma
07/10/2003WO2003056034A2 Method for the in vitro selection of binders
07/10/2003WO2003056033A1 Non- or minimally invasive monitoring methods
07/10/2003WO2003056032A1 Amp kinase beta-subunit oligosaccharide binding domain
07/10/2003WO2003056031A2 Method and kit for detecting alkaline sphingomyelinase
07/10/2003WO2003056030A2 Methods and systems of nucleic acid sequencing
07/10/2003WO2003056012A1 A system for stable expression of sirnas in mammalian cells
07/10/2003WO2003056005A1 Human sglt homolog promoter and use thereof
07/10/2003WO2003055997A1 Genomic sequences encoding dendritic cell expressed s-adenosyl homocysteine hydrolase like molecules
07/10/2003WO2003055994A1 Hxhv virus, nucleic material, peptide material and uses
07/10/2003WO2003055989A2 Cellular compositions and methods of making and using them
07/10/2003WO2003055982A2 Compositions and methods relating to endometrial specific genes and proteins
07/10/2003WO2003055980A2 Il-17 like molecules and uses thereof
07/10/2003WO2003055978A2 Gene recombination and hybrid protein development
07/10/2003WO2003055915A2 Human netrin receptor and uses thereof
07/10/2003WO2003055914A2 Modified receptors for the discovery of therapeutic ligands
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055911A2 Cystine-knot fold protein
07/10/2003WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003WO2003055908A2 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
07/10/2003WO2003055904A2 Peptidyl-trna hydrolase from pseudomonas aeruginosa
07/10/2003WO2003055899A2 Oxidized fungal antigens and methods of making and using thereof
07/10/2003WO2003055895A1 A process for preparing haptens for immunoassay of phosphorothiate pesticides
07/10/2003WO2003055530A1 Chorioallantoic membrane (cam) assay for identifying agents with biological effects
07/10/2003WO2003055516A1 Pecam-1 modulation
07/10/2003WO2003055509A1 Agonists and antagonists of bromix for the treatment of metabolic disorders
07/10/2003WO2003055507A1 Remedies for anorexia or lifestyle-related diseases and method of screening the same
07/10/2003WO2003055506A1 Preventives/remedies for cancer
07/10/2003WO2003055505A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
07/10/2003WO2003055448A2 Antifungal compositions
07/10/2003WO2003055443A2 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003039230A3 Sample well strip
07/10/2003WO2003038402A3 A peptide-based fluorescence polarization assay for detection of antibodies to mycobacterium bovis
07/10/2003WO2003035670A3 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
07/10/2003WO2003027680A3 Makrophage-based biosensor for detection of toxic substances
07/10/2003WO2003023360A3 Methods and apparatus for conducting multiple measurements on a sample
07/10/2003WO2003020959A8 Products containing quantum of bioparticles and method for production thereof
07/10/2003WO2003020123A3 Conjunctive analysis of biological marker expression for diagnosing organ failure
07/10/2003WO2003008452A3 Bispecific monoclonal antibodies to il-12 and il-18 receptors
07/10/2003WO2003007880A3 Inhibition of behab cleavage and primary central nervous system (cns) tumors
07/10/2003WO2003005029A3 Magnetic nanoparticles for bioseparation application and methods for producing same
07/10/2003WO2003002765A3 Methods for the diagnosis of cancer based on the obcam and ntm genes
07/10/2003WO2003002749A3 Methods for the simultaneous detection of hcv antigens and hcv antibodies
07/10/2003WO2002102412A3 Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons
07/10/2003WO2002101392A3 Methods for treating disorders of the nervous and reproductive systems
07/10/2003WO2002100242A3 Detection of ovarian cancer based upon alpha-haptoglobin levels
07/10/2003WO2002095365A3 Method for determining a mass changing event
07/10/2003WO2002095060A3 Determining endometrial status by testing menstruation tissue
07/10/2003WO2002093174A3 A method of treatment of alzheimer's disease and device therefor
07/10/2003WO2002092625A3 Moraxella(branhamella) catarrhalis antigens
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002086154A3 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages
07/10/2003WO2002084251A3 Method and apparatus for detection of multiple biological materials with a heterogeneous antibody mixture
07/10/2003WO2002083060A3 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
07/10/2003WO2002079778A3 In vivo delivery methods and compositions
07/10/2003WO2002063271A3 Activity based probe analysis
07/10/2003WO2002063008A3 Intracellular signaling molecules
07/10/2003WO2002061435A3 Subunit vaccines with a2 supermotifs
07/10/2003WO2002059326A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002057417A3 Angiogenesis gene and modulators
07/10/2003WO2002055985A3 Methods and reagents for identifying rare fetal cells in the material circulation
07/10/2003WO2002052272A3 Technique and screening method for detecting reversible protein-protein interactions
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002044704A3 Catalytic carbon monoxide sensor and detection method
07/10/2003WO2002042267A3 Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
07/10/2003WO2002040996A3 Differential gene expression in specific regions of the brain in neurodegenerative diseases
07/10/2003WO2002040672A3 Compositions and methods relating to breast specific genes and proteins
07/10/2003WO2002040541A3 Transporters and ion channels
07/10/2003WO2002029381A3 Method for the analysis of abnormal particle populations
07/10/2003WO2002024896A3 Screening assays for agonists or antagonists of receptor activat or of nf-kb
07/10/2003WO2002022874A8 Oligonucleotides for labeling oligonucleotide probes and proteins
07/10/2003WO2002020464A8 Benzene tricarboxylic acid amides as insulin receptor activators
07/10/2003WO2002018581A3 G-protein coupled receptors
07/10/2003WO2002010768A9 Model for alzheimer's disease and other neurodegenerative diseases
07/10/2003WO2002010335A3 ANTIBODIES SPECIFIC FOR UNGULATE PrP
07/10/2003WO2002006531A3 Nucleic acid hairpin probes and uses thereof
07/10/2003WO2002005813A3 Method for preventing and/or decreasing amyloid production with polycyclic compounds
07/10/2003WO2002000730A9 Pd-l2 molecules: novel pd-1 ligands and uses therefor
07/10/2003WO2001096559A3 Regulatable, catalytically active nucleic acids
07/10/2003WO2001096523A3 Polynucleotides related to colon cancer
07/10/2003WO2001094638A3 Asynchronous primed pcr
07/10/2003WO2001090419A3 Methods for genetic analysis of dna to detect sequence variances
07/10/2003WO2001088193A3 Follicle stimulating hormone stimulated genes and uses thereof
07/10/2003WO2001086296A3 Highly multiplexed reporter carrier systems
1 ... 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 ... 3937